Brain Outcomes With Lifestyle Change in Down Syndrome
Part of paid clinical trials in Kansas City, Kansas.
- Sponsor
- University of Kansas Medical Center
- Study ID
- NCT05985486
- Status
- Recruiting
Conditions
- Alzheimer Disease
- Down Syndrome
- Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- Diet — BEHAVIORALA reduced calorie diet which uses frozen meals purchased at the store and focuses on increasing fruits and vegetables associated with brain health.
- Health Education — BEHAVIORALMonthly health education sessions delivered remotely.
Study Details
The goal of this study is to determine if weight loss or changes in dietary intake can help prevent of delay adults with Down syndrome from developing Alzheimer's Disease Adults with Down syndrome without dementia will be randomized to either a weight loss group or a general health education control group. The weight loss group will be asked to follow a reduced energy diet, attend monthly education sessions delivered remotely and self-monitor diet and body weight using commercially available web-based applications. The control group will be asked to attend remotely delivered monthly education sessions on general health education topics. All participants will come to the University of Kansas Medical Center, 3 times across 12 months for a blood draw, cognitive testing, a MRI, assessment of height and weight, and assessment of diet intake.
Key Dates
- Start date
- Oct 22, 2024
- Status verified
- Mar 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 81 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Weight Loss* Follow a reduced calorie diet daily for 12 months. * Attend monthly behavioral counseling/education
- Active Comparator: General Health Education Control\- Attend monthly health education sessions about general health.
Primary Outcome Measure
Plasma Amyloid beta 42:40 ratio [ Time Frame: Baseline, 6, 12 months ]
Central Contacts
- Lauren Ptomey, PhD913-588-7982
- Jessica Danon785-764-3574
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | Lauren Ptomey, PhD |
Find similar trials in Kansas City, KS
Related Studies
- Trial-Ready Cohort-Down Syndrome (TRC-DS)Recruiting · University of Southern California · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- International Weight Control RegistryRecruiting · Tufts University · Birmingham, Alabama
- Mitigating the Pro-inflammatory Phenotype of ObesityPHASE1 · Recruiting · University of Kansas Medical Center · Kansas City, Kansas